We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

22 hedge funds and large institutions have $5.54M invested in Alexza Pharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

21% less funds holding

Funds holding: 2822 (-6)

53% less capital invested

Capital invested by funds: $11.7M → $5.54M (-$6.19M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
22
Holders Change
-6
Holders Change %
-21.43%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
5
Reduced
4
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
-$7K -3,489 Closed
BIM
27
BlackRock Investment Management
Delaware
-$6K -3,066 Closed
HCMT
28
Highland Capital Management (Tennessee)
Tennessee
+$510 +340 New

ALXA Hedge Fund Activity: Q2 2015 in Review

22 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2015, worth a combined $5.54M — down 53% from $11.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ALXA and 3 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Virtu KCG Holdings, opening a new position worth an estimated $35K. The largest seller was C WorldWide Group, exiting entirely with an estimated $829K sold.

  • 22 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2015, down from 28 in Q1 2015.
  • Funds reported $5.54M of Alexza Pharmaceuticals Inc stock for Q2 2015, down 53% quarter-over-quarter.
  • 3 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2015 and 9 closed out, a net change of -6 holders.
  • The largest Alexza Pharmaceuticals Inc buyer in Q2 2015 was Virtu KCG Holdings, an estimated $35K added.
  • The largest Alexza Pharmaceuticals Inc seller in Q2 2015 was C WorldWide Group, an estimated $829K sold.

Based on aggregated 13F filings for Q2 2015.